Z16.39
Resistance to other specified antimicrobial drug
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code Z16.39 refers to a condition characterized by resistance to specific antimicrobial drugs that are used to treat bacterial infections. When bacteria develop resistance, they are no longer affected by the medications that once effectively fought them. This resistance complicates treatment options and can lead to prolonged illness, increased healthcare costs, and a higher risk of complications. Recognizing and understanding antimicrobial resistance is essential for healthcare providers and patients alike to manage infections more effectively and promote responsible use of antibiotics.
Causes & Symptoms
Clinical Causes: Overuse or misuse of antibiotics which applies selective pressure on bacteria, encouraging resistant strains to develop. Incomplete courses of antibiotic treatment, allowing some bacteria to survive and develop resistance. Use of broad-spectrum antibiotics when narrow-spectrum agents would suffice, disrupting normal flora and selecting for resistant organisms. Infection with bacteria that already possess resistance mechanisms due to genetic mutations or acquisition of resistance genes. Inadequate infection control practices in healthcare settings, facilitating the spread of resistant bacteria. Environmental contamination and the use of antibiotics in agriculture and animal husbandry contributing to resistance patterns.
Key Symptoms: Persistent or worsening infection symptoms despite antibiotic treatment. Infections that take longer to resolve or recur after initial treatment. Signs of severe or systemic infection, such as fever, chills, or fatigue, especially when standard antibiotics fail. Infections caused by bacteria that are difficult to culture or identify due to resistance. Limitations in treatment options leading to prognosis challenges.
Diagnostic & Treatment
Diagnosis Path: These methods help healthcare providers select the most effective treatment options and monitor resistance patterns.
Treatment Protocols: - Antibiotic stewardship programs to promote appropriate use of antimicrobial agents and limit further resistance development.
Clinical Advice & FAQs
Billing Guidance
Is Z16.39 a billable ICD-10 code?
Yes, Z16.39 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z16.39?
Clinical documentation must specify the nature of Resistance to other specified antimicrobial drug and any associated comorbidities for accurate reporting.
Cite this Clinical Reference